Susanna Naggie, MD

Associate Professor of Medicine
Member in the Duke Clinical Research Institute
Campus mail 200 Morris Street, 6th Floor - 6410, Durham, NC 27701
Phone (919) 684-2584
Email address susanna.naggie@duke.edu

Dr. Susanna Naggie completed her medical education at Johns Hopkins School of Medicine and her internal medicine training at Duke University Medical Center (DUMC), where she also served as a Chief Resident in Internal Medicine.  She completed her Infectious Diseases (ID) fellowship training at Duke and then joined the faculty in the Division of ID. She is an Associate Professor of Medicine with Tenure and currently holds joint appointments at the Duke Clinical Research Institute (DCRI, Director of ID Research), and at the Durham Veterans Affairs Medical Center (DVAMC). Dr. Naggie has dedicated her academic career to the care of patients with HIV and viral hepatitis, with a research program focused on understanding the mechanisms of accelerated liver fibrogenesis in this population and the extrahepatic health outcomes attributed to HCV in persons with HIV infection. In addition to her investigator-initiated research program, Dr. Naggie is also involved in multiple clinical trials and clinical registries with a particular focus on HIV and liver disease. She is the prior co-Chair of the AASLD/IDSA HCV Guidance Committee and is currently Chair of the AIDS Clinical Trials Group Viral Hepatitis Transformative Science Group Committee and a member of the DHHS Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents Living with HIV and the CDC/NIH/IDSA-HIVMA Opportunistic Infections Guideline Committee. For the past two years Dr. Naggie has served as the Medical Director of the Duke Department of Medicine Clinical Research Unit.

Education and Training

  • Fellow in Infectious Diseases, Medicine, Duke University, 2007 - 2009
  • Chief Medical Resident - VAMC, Medicine, Duke University, 2006 - 2007
  • Medical Resident, Medicine, Duke University, 2002 - 2005
  • M.D., Johns Hopkins University, 2002

Publications

Lok, Anna S., Raymond T. Chung, Hugo E. Vargas, Arthur Y. Kim, Susanna Naggie, and William G. Powderly. “Comments on cochrane review on direct-acting antivirals for hepatitis C..” Hepatology 66, no. 4 (October 2017): 1016–19. https://doi.org/10.1002/hep.29366.

PMID
28714142
Full Text

Wyles, David, Norbert Bräu, Shyam Kottilil, Eric S. Daar, Peter Ruane, Kimberly Workowski, Anne Luetkemeyer, et al. “Sofosbuvir and Velpatasvir for the Treatment of Hepatitis C Virus in Patients Coinfected With Human Immunodeficiency Virus Type 1: An Open-Label, Phase 3 Study..” Clin Infect Dis 65, no. 1 (July 1, 2017): 6–12. https://doi.org/10.1093/cid/cix260.

PMID
28369210
Full Text

Burton, Mary Jane, and Susanna Naggie. “Real-World Effectiveness of DAA Therapies in Human Immunodeficiency Virus/Hepatitis C Virus Coinfection: 996 Veterans Can't Be Wrong..” Clin Infect Dis 64, no. 12 (June 15, 2017): 1721–23. https://doi.org/10.1093/cid/cix117.

PMID
28199517
Full Text

Naggie, Susanna, Kristen M. Marks, Michael Hughes, Daniel S. Fierer, Christine Macbrayne, Arthur Kim, Kimberly Hollabaugh, et al. “Sofosbuvir Plus Ribavirin Without Interferon for Treatment of Acute Hepatitis C Virus Infection in HIV-1-Infected Individuals: SWIFT-C..” In Clin Infect Dis, 64:1035–42, 2017. https://doi.org/10.1093/cid/cix025.

PMID
28329053
Full Text

Ho, Samuel B., Alexander Monto, Adam Peyton, David E. Kaplan, Sean Byrne, Scott Moon, Amanda Copans, et al. “Efficacy of Sofosbuvir Plus Ribavirin in Veterans With Hepatitis C Virus Genotype 2 Infection, Compensated Cirrhosis, and Multiple Comorbidities..” Clin Gastroenterol Hepatol 15, no. 2 (February 2017): 282–88. https://doi.org/10.1016/j.cgh.2016.05.024.

PMID
27237429
Full Text

Naggie, Susanna, David P. Holland, Mark S. Sulkowski, and David L. Thomas. “Hepatitis C Virus Postexposure Prophylaxis in the Healthcare Worker: Why Direct-Acting Antivirals Don't Change a Thing..” Clin Infect Dis 64, no. 1 (January 1, 2017): 92–99. https://doi.org/10.1093/cid/ciw656.

PMID
27682067
Full Text

Alam, Imtiaz, Kimberley Brown, Cynthia Donovan, Jamie Forlenza, Kris Lauwers, Mitchell A. Mah’moud, Richard Manch, et al. “Real-World Effectiveness of Simeprevir-containing Regimens Among Patients With Chronic Hepatitis C Virus: The SONET Study..” Open Forum Infect Dis 4, no. 1 (2017). https://doi.org/10.1093/ofid/ofw258.

PMID
28480251
Full Text

Younossi, Z. M., M. Stepanova, M. Sulkowski, S. Naggie, L. Henry, and S. Hunt. “Sofosbuvir and ledipasvir improve patient-reported outcomes in patients co-infected with hepatitis C and human immunodeficiency virus..” In J Viral Hepat, 23:857–65, 2016. https://doi.org/10.1111/jvh.12554.

PMID
27291391
Full Text

Pages